BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 1355599)

  • 1. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experiences with pipecuronium bromide.
    Boros M; Szenohradszky J; Kertész A; Marosi G; Tutsek L
    Acta Chir Hung; 1983; 24(4):207-14. PubMed ID: 6322488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of different doses of pipecuronium bromide during nitrous-oxide-fentanyl anaesthesia in adult surgical patients.
    Sanfilippo M; Fierro G; Vilardi V; Rosa G; De Gregorio AL; Gasparetto A
    Eur J Anaesthesiol; 1992 Jan; 9(1):49-53. PubMed ID: 1310464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects].
    Sugai N; Yajima C; Numata K; Irimada T; Hashimoto Y; Itagaki T; Katsumata N; Suzuki H; Aoki T; Fukushima K
    Masui; 1990 Mar; 39(3):293-300. PubMed ID: 2161058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular effects of pipecuronium bromide.
    Stanley JC; Mirakhur RK; Bell PF; Sharpe TD; Clarke RS
    Eur J Anaesthesiol; 1991 Mar; 8(2):151-6. PubMed ID: 1651856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
    Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S
    Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopharmacology of Arduan].
    Mészáros C
    Acta Pharm Hung; 1992 May; 62(3):133-8. PubMed ID: 1354406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pipecuronium versus high dose vecuronium. I. A comparison of speed of onset and cumulation during isoflurane anaesthesia.
    Harrop-Griffiths W; Fauvel N; Plumley M; Feldman S
    Anaesthesia; 1992 Feb; 47(2):105-6. PubMed ID: 1347204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of atracurium, pipecuronium, and vecuronium for tracheal intubation.
    Cozanitis DA; Hofmockel R; Benad G; Sitarek U
    Acta Anaesthesiol Belg; 1987; 38(1):77-81. PubMed ID: 2884796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular and cardiovascular effects of atracurium during nitrous oxide-fentanyl and nitrous oxide-isoflurane anaesthesia.
    Rupp SM; Fahey MR; Miller RD
    Br J Anaesth; 1983; 55 Suppl 1():67S-70S. PubMed ID: 6688020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of atracurium, vecuronium and pancuronium on heart rate and arterial pressure in normal individuals.
    Lavery GG; Mirakhur RK; Clarke RS; Gibson FM
    Eur J Anaesthesiol; 1986 Nov; 3(6):459-67. PubMed ID: 2885185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular block: atracurium and vecuronium compared and combined.
    Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T
    Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine.
    Mehta MP; Sokoll MD; Gergis SD
    Eur J Anaesthesiol; 1988 Jan; 5(1):15-21. PubMed ID: 2897912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New muscle relaxants.
    Fahey MR; Miller RD
    Contemp Anesth Pract; 1983; 7():61-81. PubMed ID: 6136393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of pipecuronium bromide.
    Larijani GE; Bartkowski RR; Azad SS; Seltzer JL; Weinberger MJ; Beach CA; Goldberg ME
    Anesth Analg; 1989 Jun; 68(6):734-9. PubMed ID: 2544118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the haemodynamic effects of pipecuronium and pancuronium during fentanyl anaesthesia.
    Stanley JC; Carson IW; Gibson FM; McMurray TJ; Elliott P; Lyons SM; Mirakhur RK
    Acta Anaesthesiol Scand; 1991 Apr; 35(3):262-6. PubMed ID: 1645492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative pharmacokinetics of pipecuronium bromide, pancuronium bromide and vecuronium bromide in anesthetized man].
    Yajima C; Sugai N; Hanaoka K; Numata K; Yamamoto K; Kushida Y; Murakami S; Yamamura H
    Masui; 1990 Jul; 39(7):882-9. PubMed ID: 1976829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.
    Wierda JM; Richardson FJ; Agoston S
    Anesth Analg; 1989 Mar; 68(3):208-13. PubMed ID: 2537588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on the neuromuscular blocking action of pipecuronium in the dog.
    Jones RS
    Res Vet Sci; 1987 Jul; 43(1):101-3. PubMed ID: 2820005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.